Dr Huseyin Naci PhD MHS

Dr Huseyin Naci PhD MHS

Assistant Professor

Department of Health Policy

Telephone
020 7955 6874
Extension
6874
Room No
COW.3.01
Connect with me

About me

Huseyin Naci is an Assistant Professor of Health Policy at the London School of Economics and Political Science. During the 2018-2019 academic year, he is a UK Harkness Fellow in Health Care Policy and Practice at the Harvard Kennedy School of Government and Harvard Medical School.

His research to date has evaluated the quality and quantity of the evidence base underpinning the approval, adoption, and reimbursement of new pharmaceutical and health technologies in Europe and the US. Naci’s research has appeared in leading health policy and general medical journals including JAMA, BMJ, Health Affairs, and The Milbank Quarterly. He has a PhD in Health Policy from the Department of Social Policy at the LSE and an MHS in International Health from the Johns Hopkins Bloomberg School of Public Health.

Prior to joining LSE, he was a Thomas O. Pyle Fellow in Population Medicine at Harvard University (2013-2014) and a Fellow in Pharmaceutical Policy Research at Harvard Medical School and Harvard Pilgrim Health Care Institute (2012-2013), both in Boston, USA.

 

Current research

Dr Naci’s academic focuses on evidence-based decision making health care, especially within the broader domains of pharmaceutical policy and regulation, comparative effectiveness research, and health policy evaluation.

Publications 

 

Education

PhD Pharmaceutical Policy and Economics, London School of Economics and Political Science (2014)
MHS International Health and Health Economics, Johns Hopkins University Bloomberg School of Public Health (2008)
BA Biochemistry, Knox College (2006)

 

Teaching

HP407 Evidence Review and Synthesis
HP4C4E Systematic Review and Meta-analysis

 

LSE Affiliations

LSE Health

 

External affiliations

Affiliated faculty, Program on Regulation, Therapeutics and Law (PORTAL), Brigham & Women’s Hospital and Harvard Medical School

 

Expertise

pharmaceutical policy and regulation; FDA; EMA; NICE; health policy; policy evaluation; comparative effectiveness research; network meta-analysis